ANI Pharmaceuticals, Inc. (ANIP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 747.08M | 753.12M | 698.4M | 602.63M | 536.29M | 527.68M | 521.3M | 555.46M | 540.56M | 519.82M | 497.22M | 459.31M |
| Cash & Short-Term Investments | 311.18M | 285.58M | 262.61M | 223.51M | 155.19M | 151.17M | 153.28M | 247.05M | 238.25M | 221.12M | 193.08M | 161.71M |
| Cash Only | 311.18M | 285.58M | 262.61M | 217.8M | 149.8M | 144.86M | 144.98M | 240.11M | 228.6M | 221.12M | 193.08M | 161.71M |
| Short-Term Investments | 0 | 0 | 0 | 5.72M | 5.39M | 6.31M | 8.3M | 6.94M | 9.65M | 0 | 0 | 0 |
| Accounts Receivable | 255.43M | 281.08M | 252.62M | 225.65M | 220.33M | 221.73M | 196.36M | 166.09M | 172.42M | 162.08M | 178.84M | 172.93M |
| Days Sales Outstanding | 101.67 | 99.37 | 96.57 | 96 | 100.92 | 100.92 | 112.4 | 111.58 | 110.74 | 119.12 | 122.74 | 135.72 |
| Inventory | 143.47M | 143.07M | 146.47M | 138.31M | 137.41M | 136.78M | 148.04M | 125.45M | 113.84M | 111.2M | 106.59M | 104.32M |
| Days Inventory Outstanding | 112.61 | 1.4K | 112.91 | 168.13 | 168.94 | 163.2 | 199.45 | 188.7 | 208.29 | 187.54 | 201.7 | 223.8 |
| Other Current Assets | 37.01M | 43.38M | 36.7M | 15.15M | 23.36M | 18.01M | 17.51M | 14M | 16.05M | 25.42M | 18.71M | 16.27M |
| Total Non-Current Assets | 674.89M | 687.26M | 709.75M | 740.37M | 756.14M | 756.01M | 766.08M | 365.29M | 373.97M | 384.61M | 392.69M | 400.03M |
| Property, Plant & Equipment | 67.11M | 62.48M | 63.56M | 59.25M | 58.18M | 56.86M | 56.7M | 51.64M | 48.53M | 44.59M | 44.19M | 44.37M |
| Fixed Asset Turnover | 3.66x | 3.92x | 3.71x | 3.60x | 3.43x | 3.36x | 2.74x | 2.76x | 2.95x | 2.97x | 2.98x | 2.66x |
| Goodwill | 62.48M | 62.48M | 62.48M | 60.53M | 60.66M | 59.99M | 60.43M | 28.22M | 28.22M | 28.22M | 28.22M | 28.22M |
| Intangible Assets | 467.16M | 479.53M | 499.82M | 520.32M | 538.5M | 541.83M | 569.83M | 183.08M | 196.04M | 209.01M | 219.83M | 230.3M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 11.57M | 13.71M | 12.5M | 8.25M | 10.31M | 12.22M | 11.46M | 12.85M | 13.57M | 12.07M | 16.07M | 15.64M |
| Total Assets | 1.42B | 1.44B | 1.41B | 1.34B | 1.29B | 1.28B | 1.29B | 920.75M | 914.52M | 904.42M | 889.91M | 859.34M |
| Asset Turnover | 0.17x | 0.17x | 0.17x | 0.16x | 0.15x | 0.15x | 0.13x | 0.15x | 0.15x | 0.15x | 0.15x | 0.14x |
| Asset Growth % | 10.02% | 12.21% | 9.38% | 45.86% | 41.32% | 41.94% | 44.66% | 7.15% | 19.51% | 18.99% | 20.4% | 14.38% |
| Total Current Liabilities | 239.51M | 278.11M | 270.56M | 236.84M | 201.81M | 193.68M | 189.93M | 139.98M | 136.89M | 145.48M | 134.35M | 122.86M |
| Accounts Payable | 69.69M | 62.58M | 69.8M | 54.57M | 53.06M | 45.66M | 60.89M | 48.68M | 49.43M | 36.68M | 34.08M | 28.5M |
| Days Payables Outstanding | 51.99 | 640.99 | 49.31 | 65.63 | 60.82 | 61.05 | 79.91 | 77.37 | 79.71 | 60.93 | 59.85 | 65.85 |
| Short-Term Debt | 19.3M | 17.27M | 15.24M | 13.22M | 11.19M | 9.17M | 7.15M | 850K | 850K | 850K | 850K | 850K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 150.52M | 198.26M | 185.52M | 82.1M | 64.99M | 77.03M | 68.13M | 50.85M | 42.79M | 65.73M | 70.7M | 66.32M |
| Current Ratio | 3.12x | 2.71x | 2.58x | 2.54x | 2.66x | 2.72x | 2.74x | 3.97x | 3.95x | 3.57x | 3.70x | 3.74x |
| Quick Ratio | 2.52x | 2.19x | 2.04x | 1.96x | 1.98x | 2.02x | 1.97x | 3.07x | 3.12x | 2.81x | 2.91x | 2.89x |
| Cash Conversion Cycle | 162.3 | 860.37 | 160.18 | 198.51 | 209.03 | 203.07 | 231.95 | 222.91 | 239.33 | 245.72 | 264.6 | 293.67 |
| Total Non-Current Liabilities | 620.16M | 621.54M | 631.78M | 644.56M | 647.14M | 661.49M | 666.65M | 300.17M | 300.82M | 301.35M | 300.85M | 302M |
| Long-Term Debt | 308.47M | 307.93M | 307.39M | 608.35M | 611.63M | 614.92M | 618.21M | 284.39M | 284.61M | 284.82M | 285.03M | 285.24M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 311.69M | 313.61M | 324.39M | 36.21M | 35.51M | 46.57M | 48.44M | 15.77M | 16.21M | 16.53M | 15.82M | 16.76M |
| Total Liabilities | 859.67M | 899.65M | 902.34M | 881.39M | 848.96M | 855.17M | 856.58M | 440.14M | 437.71M | 446.82M | 435.2M | 424.87M |
| Total Debt | 327.76M | 325.19M | 322.63M | 621.56M | 622.82M | 624.09M | 625.36M | 285.24M | 285.46M | 285.67M | 285.88M | 286.09M |
| Net Debt | 16.59M | 39.61M | 60.02M | 403.76M | 473.02M | 479.23M | 480.38M | 45.13M | 56.86M | 64.55M | 92.8M | 124.39M |
| Debt / Equity | 0.58x | 0.60x | 0.64x | 1.35x | 1.40x | 1.46x | 1.45x | 0.59x | 0.60x | 0.62x | 0.63x | 0.66x |
| Debt / EBITDA | 5.50x | 4.59x | 7.10x | 16.72x | 12.69x | 34.25x | - | 14.36x | 8.16x | 13.03x | 8.62x | 10.56x |
| Net Debt / EBITDA | 0.28x | 0.56x | 1.32x | 10.86x | 9.64x | 26.30x | - | 2.27x | 1.62x | 2.94x | 2.80x | 4.59x |
| Interest Coverage | 10.27x | 2.38x | 8.15x | 1.94x | 3.14x | -1.29x | -12.51x | 0.51x | 6.51x | 1.16x | 2.80x | 1.74x |
| Total Equity | 562.3M | 540.72M | 505.82M | 461.61M | 443.47M | 428.53M | 430.8M | 480.61M | 476.81M | 457.6M | 454.71M | 434.47M |
| Equity Growth % | 26.8% | 26.18% | 17.41% | -3.95% | -6.99% | -6.35% | -5.26% | 10.62% | 40.45% | 35.17% | 35.06% | 28.94% |
| Book Value per Share | 26.10 | 25.47 | 23.98 | 22.73 | 22.12 | 22.04 | 22.20 | 24.88 | 24.55 | 23.81 | 23.78 | 24.33 |
| Total Shareholders' Equity | 562.3M | 540.72M | 505.82M | 461.61M | 443.47M | 428.53M | 430.8M | 480.61M | 476.81M | 457.6M | 454.71M | 434.47M |
| Common Stock | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K |
| Retained Earnings | 6.39M | -23.1M | -50.59M | -76.86M | -85M | -100.28M | -89.6M | -65.03M | -62.33M | -80.13M | -80.88M | -90.41M |
| Treasury Stock | 0 | 0 | 0 | -31.59M | -31.04M | -21.04M | -20.72M | -20.04M | -18.74M | -10.08M | -9.85M | -9.18M |
| Accumulated OCI | 479K | 1.03M | 2.81M | 3.31M | 3.61M | 5.34M | 5.37M | 8.33M | 9.41M | 8.86M | 14.08M | 13.73M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |